Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock?

Johnson & Johnson (JNJ -0.47%) didn't have an exceptional 2024; in fact, it was one of the worst-performing stocks on the vaunted, 30-company Dow Jones Industrial Average that year.Yet, if the company's inaugural earnings release in 2025 is any indication, this year might prove to be different. It posted encouraging growth on the top line and notched a double beat on analyst estimates. Here's the skinny on that quarter and whether the rest of the year will be healthy enough to rank the company's stock as a ...